Tyrell Inc. Takes Part In ERSP Forum

New York, NY –  May  9,  2007 – The Electronic Retailing Self-Regulation Program (ERSP) has determined that Tyrell Inc., marketers of the Zeno Acne Treatment Device (Zeno), have adequately supported certain claims, but recommended the addition of disclosures to advertising for the product.

The marketer’s advertis ing was reviewed pursuant to an anonymous challenge.

ERSP,  the  electronic  direct-response  industry’s  self-regulatory  forum,  is  administered  by  the Council of Better Business Bureaus (CBBB) with policy oversight by the National Advertising Review Council (NARC).

Claims at issue in the ERSP inquiry included:

  • “In clinical trials, 90 percent of blemishes treated with Zeno disappeared or faded within 24 hours”
  • “Zeno, the first FDA-cleared medical device designed to treat mild to moderate acne, has 90 percent efficacy in clinical trials-resolving most blemishes within 24 hours” “Announcing Zeno: dermatologist recommended to clear up pimples. Fast.”
  • “In fact, for treating acne pimples, it’s the most scientifically advanced and effective device available without a prescription.”

ERSP found that the clinical testing provided by Tyrell provided a reasonable basis for its claim that “In clinical trials, 90 percent of blemishes treated with Zeno disappeared or faded within 24 hours,” and found that the marketer provided a reasonable basis for its comparative claim that Zeno is “the most scientifically advanced and effective device available without a prescription.” ERSP further determined that the marketer adequately supported its claim that Zeno is “the first FDA-cleared medical device designed to treat mild to moderate acne.”

However, ERSP recommended the marketer modify its advertising to disclose that its testing was done on subjects with mild or moderate acne conditions and the quantified claim was limited to treatment of these types of acne. ERSP recommended also the marketer include appropriate disclaimer language to the consumer testimonial section of the Website.

The company, in its marketer’s statement, said “Tyrell appreciates the opportunity to have worked with the ERSP self-regulatory program to provide consumers with truthful and accurate advertising.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends T-Mobile Discontinue or Modify 20% Savings vs. ‘The Other Big Guys’ Claim; T-Mobile to Appeal

New York, NY – January 9, 2025 – The National Advertising Division recommended that T-Mobile discontinue or modify its advertising to avoid conveying the comparative claim that consumers can “save 20% every month vs. the other big guys” if they subscribe to T-Mobile in markets where Spectrum Mobile also...

Read the Decision Summary
Decision

In National Advertising Division Fast-Track SWIFT Challenge Behr Voluntarily Discontinues “No Comparable Product” Claim

New York, NY – January 8, 2025 – In a National Advertising Division Fast-Track SWIFT challenge brought by Benjamin Moore, Behr voluntarily discontinued its “No Comparable Product” claim.

Read the Decision Summary
Decision

National Advertising Division Finds Charter’s “Unlimited” Claims Supported; Recommends Clear & Conspicuous Speed Limitation Disclosures

New York, NY – January 7, 2025 – The National Advertising Division found that Charter substantiated certain express and implied claims about its Spectrum Mobile “Unlimited” and “Unlimited Plus” wireless data plans but recommended that Charter modify its website advertising to disclose high speed data...

Read the Decision Summary
Decision

National Advertising Division Recommends Solawave Discontinue Certain Claims for its Advanced Skincare Wand

New York, NY – January 6, 2025 – As part of its routine monitoring process, the National Advertising Division recommended Solawave discontinue certain express and implied claims for its SolaWave Advanced Skincare Wand.

Read the Decision Summary